Загрузка...
Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia
Chimeric antigen receptor (CAR) T-cell therapy has already achieved remarkable remissions in some difficult-to-treat patients with B-cell malignancies. Although the clinical experience in chronic lymphocytic leukemia (CLL) patients is limited, the proportion of remissions reached in this disease is...
Сохранить в:
| Опубликовано в: : | Int J Mol Sci |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8197365/ https://ncbi.nlm.nih.gov/pubmed/34073911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22115536 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|